These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10904611)

  • 1. [1999 Robert Koch Drug Award for enoxaparin. Safely preventing thromboembolism].
    Stiefelhagen P
    MMW Fortschr Med; 1999 Sep; 141(38):18. PubMed ID: 10904611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Care for life. Central is the patient].
    Hilpert U
    Internist (Berl); 2000 Jan; 41(1):A37. PubMed ID: 10712086
    [No Abstract]   [Full Text] [Related]  

  • 3. Best evidence in anesthetic practice: prevention: fondaparinux is better than enoxaparin for prevention of major venous thromboembolism after orthopedic surgery.
    Hardy JF
    Can J Anaesth; 2003 Oct; 50(8):764-6. PubMed ID: 14525813
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for venous thromboembolism.
    Lawrence YR
    Arch Intern Med; 2004 Nov; 164(21):2386. PubMed ID: 15557421
    [No Abstract]   [Full Text] [Related]  

  • 5. Enoxaparin for the prevention of venous thromboembolism.
    Sosis MB
    N Engl J Med; 2000 Jan; 342(2):136; author reply 137. PubMed ID: 10636757
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stroke. Enoxaparin sodium inhibits venous thromboembolism compared to unfractionated heparin].
    Drossbach M
    Med Monatsschr Pharm; 2007 Nov; 30(11):426. PubMed ID: 18062340
    [No Abstract]   [Full Text] [Related]  

  • 7. Once-daily enoxaparin in pediatric thromboembolism: a dose finding and pharmacodynamics/pharmacokinetics study.
    O'Brien SH; Lee H; Ritchey AK
    J Thromb Haemost; 2007 Sep; 5(9):1985-7. PubMed ID: 17596139
    [No Abstract]   [Full Text] [Related]  

  • 8. Enoxaparin for the prevention of venous thromboembolism.
    Hynson JM
    N Engl J Med; 2000 Jan; 342(2):136; author reply 137. PubMed ID: 10636756
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
    Tebbe U
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment: low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
    Spinler SA; Friedman RJ
    Ann Pharmacother; 2005 Nov; 39(11):1954-5; author reply 1955. PubMed ID: 16204385
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease.
    Kleber FX; Witt C; Vogel G; Koppenhagen K; Schomaker U; Flosbach CW;
    Am Heart J; 2003 Apr; 145(4):614-21. PubMed ID: 12679756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients.
    Frederiksen SG; Hedenbro JL; Norgren L
    Br J Surg; 2003 May; 90(5):547-8. PubMed ID: 12734859
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tapentadol for pain; enoxaparin after prosthetic valve replacement.
    DeDea L
    JAAPA; 2011 Jul; 24(7):14. PubMed ID: 21748951
    [No Abstract]   [Full Text] [Related]  

  • 15. Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective.
    de Lissovoy G; Subedi P
    Am J Manag Care; 2002 Dec; 8(12):1082-8. PubMed ID: 12500884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of venous thromboembolisms].
    Wagner W
    Med Klin (Munich); 2010 Sep; 105(9):674; author reply 675. PubMed ID: 20878306
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of heparin in prevention of deep veins thrombosis and pulmonary artery thromboembolism in therapeutic regime patients].
    Panchenko EP
    Klin Med (Mosk); 2001; 79(3):59-62. PubMed ID: 11490422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks and benefits of chemoprophylaxis.
    Lotke PA
    J Bone Joint Surg Am; 2002 May; 84(5):879-80; author reply 880. PubMed ID: 12004043
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of venous thromboembolism after orthopedic surgery: the EXPRESS study.
    Cimminiello C; Planès A; Samama MM
    J Thromb Haemost; 2004 Nov; 2(11):2036-40. PubMed ID: 15550036
    [No Abstract]   [Full Text] [Related]  

  • 20. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.